NRAS and leukemia: Our results are supported by previous studies which show that palmostatin B mediated inhibition of APT-1 and -2 affects HRASG12 transformed fibroblasts, NRASG12 transformed fetal liver cells and NRAS mutant leukemia cells [26,42].